3 completed, 1 withdrawn. 4 Phase 1, 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 3, Withdrawn 1 |
| Phase 2 | 4 | Completed 3, Withdrawn 1 |
Follow Intravenous Ketamine: new trials by email Literature Review of Intravenous Ketamine trials Research Report on Intravenous Ketamine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Repeated Neurocognitive Measurements in Depressed Patients Intravenous Ketamine - Depression, Unipolar | Phase 1 / Phase 2 | Withdrawn | Jay Fournier | 2025-05-01 | 2026-02-25 | |
| Ketamine + Mindfulness for Depression Intravenous Ketamine, Brief Mindfulness Exercises, Academic Exercises - Depression, Unipolar | Phase 1 / Phase 2 | Completed | Rebecca Price | 43 | 2022-02-01 | 2024-08-20 |
| Repeated Neurocognitive Measurements in Depressed Patients Intravenous Ketamine - Depression, Unipolar | Phase 1 / Phase 2 | Completed | Rebecca Price | 15 | 2021-09-16 | 2024-08-20 |
| Intravenous Ketamine Plus Neurocognitive Training for Depression Intravenous ketamine, Computer-based Cognitive Training - Depression | Phase 1 / Phase 2 | Completed | Rebecca Price | 154 | 2017-12-01 | 2024-03-19 |
Depressive Disorder (3) · Depression (1) · Mental Disorders (1) · Mood Disorders (1)
Rebecca Price (3) · Jay Fournier (1)
United States (4)
PMID 33271040, PMID 37155171, PMID 39311825, PMID 40964432
R01MH113857 (1)